Ropivacaine Hydrochloride Injection — FDA Drug Shortage

Current — Somerset Therapeutics, LLC

The FDA lists a drug shortage record for Ropivacaine Hydrochloride Injection (injection) from Somerset Therapeutics, LLC with status Current. The shortage was first posted on Mar 23, 2018.

Shortage details

Status
Current
Company
Somerset Therapeutics, LLC
Package NDC
70069-061-10
Dosage Form
Injection
Presentation
Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10)
Initial Posting
Mar 23, 2018

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.